Archive
Past Programs (2023-1977)
| Year | Title | Program |
| 2023 | Lipids in Aging, Lifespan and Aging-Associated Diseases | |
| 2022 | Therapeutic Aspects of Adipose Tissue Organ Crosstalk | |
| 2021 | Meeting cancelled due to COVID-19 pandemic | |
| 2020 | Meeting cancelled due to COVID-19 pandemic | |
| 2019 | Signaling Lipids In Health and Disease | |
| 2018 | Metabolic Regulation of Immunity, Cardiometabolic Diseases, and Cancer: New Therapeutic Approaches |
|
| 2017 | The Gut Microbiome, Bile Acids, and Regulatory Networks in Health and Disease: Emerging Therapeutic Approaches |
|
| 2016 | Targets/Therapies for Diabetes, Atherosclerosis and NASH: A Dialogue between Academia and Industry on Innovation |
|
| 2015 | Emerging Therapies for Cardiovascular Metabolic Disease: A Dialogue between Academia and Industry |
|
| 2014 | Evolving Concepts of HDL Function in Cardiometabolic Diseases and Beyond | |
| 2013 | Molecular Mechanisms and Pathophysiology of Lipid Storage | |
| 2012 | Systems Biology, Lipidomics and Cardiometabolic Diseases | |
| 2011 | Emerging Discoveries of Lipid Effects on Organ Physiology and Pathobiology | |
| 2010 | Lipids, Inflammation, and Stress Reactions in Atherosclerosis: Mechanisms, Imaging, and Therapy |
|
| 2009 | Role of Nuclear Receptors and Coregulators in Insulin Resistance, Energy and Lipid Metabolism, Inflammation and Aging | |
| 2008 | Frontiers in Regulation of Lipid Metabolism | |
| 2007 | Diabetes, Obesity and Atherosclerosis | |
| 2006 | Developments in the Pathogenesis of Obesity and the Metabolic Syndrome | |
| 2005 | HDL Metabolism and Nuclear Receptors: A New Frontier for the Treatment of Atherosclerosis | |
| 2004 | Inflammation and Atherosclerosis | |
| 2003 | Integrative Mechanisms of Lipid Metabolism | |
| 2002 | Fatty Acid Transport and Metabolism: Impact on Insulin Action/Secretion and Body Weight Regulation |
|
| 2001 | Cholesterol Metabolism in Health and Disease: ABC Transporters, Lipid Trafficking and Atherosclerosis |
|
| 2000 | New Insight to Atherosclerosis: Pathogenesis, Diagnosis, and Treatment | |
| 1999 | Lipids as Modulators of Gene Expression: Lipid Metabolism and Atherosclerosis | |
| 1998 | Lipid Metabolism in Health and Disease: Cholesterol Transport, Atherosclerosis, and Alzheimer's Disease | |
| 1997 | Lipids, Insulin Resistance and Obesity | |
| 1996 | Lipids, Lipoproteins and Obesity | |
| 1995 | Quantification of the Major Lipoprotein Pathways | |
| 1994 | Fatty Acid Metabolism in Liver and Adipose Tissue | |
| 1993 | Genetics and Diet Responsiveness in Cholesterol Metabolism | |
| 1992 | Regulation of Hepatic Cholesterol Transport and Metabolism | |
| 1991 | Lipid Accumulation in Hepatic and Extrahepatic Tissues | |
| 1990 | Hepatic Cholesterol and Postprandial Lipoproteins | |
| 1989 | Hepatic Cholesterol and Lipoprotein | |
| 1988 | Hepatic Cholesterol and Lipoprotein | |
| 1987 | Hepatic Lipoprotein and Cholesterol Metabolism | |
| 1985 | Regulation of Bile Acid Synthesis | |
| 1979 | Workshop on Regulation of Hepatic Cholesterol and Bile Acid Metabolism | |
| 1977 | Hepatic and Bilary Lipids |